Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Rhoifolin improves bleomycin-induced fibrosis in vivo and cell damage in vitro both related to NRF2/HO-1 pathway
Fengxia Xiao, Xuehua Wang, Jun Zhang, Qing Wang et al.
Citations
2 citations
Journal
BMC Pulmonary Medicine
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Field-Weighted Citation Impact (FWCI)
3.04
article
Rhoifolin improves bleomycin-induced fibrosis in vivo and cell damage in vitro both related to NRF2/HO-1 pathway
Fengxia Xiao, Xuehua Wang, Jun Zhang, Qing Wang, Ling Han, Liang Liu, Jingjing Wu, Panyu Zhou, Fanlu Liu, Haojie Su
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC Pulmonary MedicineVol. 25(1)
Institutions
Guangzhou University of Chinese Medicine (CN), Lingnan Normal University (CN), Zhanjiang Experimental Station (CN), First People's Hospital of Chongqing (CN)
Sustainable Development Goals
Zero hunger
OpenAlex Percentile
Openalex Percentile: Top 11%
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Rhoifolin improves bleomycin-induced fibrosis in vivo and cell damage in vitro both related to NRF2/HO-1 pathway — Fengxia Xiao, Xuehua Wang, et al. · BMC Pulmonary Medicine (2025) | TGRS Research Map | TGRS